Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001123292-25-000761·Saadi Ryan H.
Schedule 13D ownership disclosure
Tevogen Bio Holdings Inc
Common Stock, par value $0.0001 per share · CUSIP: 88165K101
Event date: 2025-12-11
- Filing-level shares
- 124,528,376.32
- Percent of class
- 62%
- Ryan H. SaadiReported CIK 0002011728
Shares: 124,528,376.32 · Class: 62%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-25-000761
- Form type
- SCHEDULE 13D/A
- Filer
- Saadi Ryan H.
- CIK
- CIK 2011728
- Filed
- Dec 16, 2025
- Reporting period
- Dec 11, 2025
- Description
- Schedule 13D beneficial ownership